#Kenya #Nairobi #Psoriasis #Health #IFPA

IFPA Hosts the First African Forum on Psoriasis

The International Federation of Psoriasis Associations (IFPA) is set to host a groundbreaking summit addressing psoriasis in Africa, scheduled for May 7-9, 2026, in Nairobi, Kenya. This inaugural regional forum, titled "Local Strength, United Action," aims to unite policymakers, clinicians, researchers, and patient organizations to combat a disease that remains largely unrecognized and underdiagnosed across the continent.

The Hidden Burden of Psoriasis in Africa

Psoriasis and psoriatic arthritis are chronic, non-communicable diseases that can lead to significant pain, disability, and economic hardship. Despite impacting over 3.5 million individuals in Africa, these conditions are often stigmatized due to their visible manifestations. This stigma can severely affect mental health and exacerbate economic difficulties, yet awareness of psoriasis remains alarmingly low.

Estimates suggest that the real burden of the disease may be even greater, as many cases go undiagnosed due to limited epidemiological data and a lack of healthcare specialists. In regions like East, West, Central, and Southern Africa, reported prevalence rates are as low as 0.06%, indicating a widespread issue of underdiagnosis.

Limited Access to Care and Economic Impact

Access to dermatological care in Africa is critically low, with only one dermatologist available for over a million people, compared to 36 per million in the United States and 65 per million in Germany. With most healthcare expenses being out-of-pocket, many patients find psoriasis treatment prohibitively expensive, leading to a cycle of poverty for affected families.

To address these challenges, the IFPA has convened this unique forum to create a comprehensive action plan alongside regional and global stakeholders, including patient advocacy groups like PsorAfrica. "Psoriasis presents a public health challenge that must be prioritized in the development of equitable health systems," emphasized Frida Dunger, Executive Director of IFPA. She noted that each year, the forum focuses on a specific region to amplify local voices and foster collaborative efforts against psoriasis.

Pierre Celestin Habiyaremye, President of PsorAfrica, emphasized the need for greater awareness, stating, "People in rural and urban areas of Africa lack sufficient knowledge about psoriasis. This ignorance impacts my life profoundly, influencing my decisions and relationships. The forum will unite experts dedicated to improving the future for those affected."

Janet Mbugua, a prominent Kenyan media personality and social change advocate, will host the forum. She expressed her honor in leading discussions focused on psoriasis, stating, "This is a vital opportunity to highlight the challenges faced by those living with the condition and support local initiatives improving care, research, and policy across the continent."

Three Urgent Priorities

The forum will center around three critical areas:

1. Research: Generating local data on psoriasis to enhance understanding and treatment.
2. Representation: Ensuring patient voices influence healthcare decision-making.
3. Access and Rights: Incorporating psoriasis into national strategies against non-communicable diseases, emphasizing the inclusion of essential medications, and combatting stigma.

About IFPA: Founded in 1971 and headquartered in Stockholm, the IFPA advocates for the interests of individuals affected by psoriatic disease globally. Its members include national and regional associations representing over 60 million people. By fostering global coalitions, campaigns for World Psoriasis Day, and organizing international forums, IFPA is redefining psoriasis as a key health priority essential for creating stronger and more inclusive health systems.